Abstract

Preexposure prophylaxis with antiretroviral therapy can lower risk for HIV acquisition, but the efficacy of this approach depends on adherence to daily use of medication (e.g., in vaginal gel). To assess the efficacy of a vaginal ring containing dapivirine, a nonnucleoside reverse-transcriptase inhibitor, investigators randomized 1959 women in South Africa and Uganda to dapivirine-containing or placebo rings changed every …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call